Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Metralindole

From Wikipedia, the free encyclopedia
Metralindole
Clinical data
Routes of
administration
Oral
Drug classMonoamine oxidase inhibitor (MAOI); Reversible inhibitor of MAO-A (RIMA)
ATC code
  • None
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
  • 2,4,5,6-tetrahydro-9-methoxy-4-methyl-1H-3,4,6a-triazafluoranthene
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC15H17N3O
Molar mass255.321 g·mol−1
3D model (JSmol)
  • CN1CCN2C3=C(C=C(C=C3)OC)C4=C2C1=NCC4

Metralindole (Inkazan) is a reversible inhibitor of monoamine oxidase A (RIMA) which was investigated in Russia as a potential antidepressant.[1] It is structurally and pharmacologically related to pirlindole.

See also

[edit]

References

[edit]
  1. Andreeva NI, Golovina SM, Faermark MF, Shvarts GI, Mashkovskiĭ MD (1991). "[The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine]". Farmakologiia i Toksikologiia (in Russian). 54 (2): 38–40. PMID 1884793.